Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis.
Scarpato S, Sebastiani M, Quartuccio L, Marson P, Fraticelli P, Castelnovo L, Visentini M, Candela M, Mazzaro C, Saccardo F, Pioltelli P, Casato M, Filippini D, Monti G, Galli M; Italian Group for the Study of Cryoglobulinaemia (GISC). Scarpato S, et al. Among authors: visentini m. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):149-154. doi: 10.55563/clinexprheumatol/2v6v5j. Epub 2021 Apr 30. Clin Exp Rheumatol. 2021. PMID: 33938790 Free article.
Efficacy of low-dose rituximab for mixed cryoglobulinemia.
Visentini M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M. Visentini M, et al. Clin Immunol. 2007 Oct;125(1):30-3. doi: 10.1016/j.clim.2007.06.008. Epub 2007 Aug 9. Clin Immunol. 2007. PMID: 17692572 Clinical Trial.
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M. Visentini M, et al. Autoimmun Rev. 2011 Sep;10(11):714-9. doi: 10.1016/j.autrev.2011.04.033. Epub 2011 May 5. Autoimmun Rev. 2011. PMID: 21570494 Clinical Trial.
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review.
Visentini M, Tinelli C, Colantuono S, Monti M, Ludovisi S, Gragnani L, Mitrevski M, Ranieri J, Fognani E, Piluso A, Granata M, De Silvestri A, Scotti V, Mondelli MU, Zignego AL, Fiorilli M, Casato M. Visentini M, et al. Autoimmun Rev. 2015 Oct;14(10):889-96. doi: 10.1016/j.autrev.2015.05.013. Epub 2015 May 29. Autoimmun Rev. 2015. PMID: 26031898 Clinical Trial.
107 results